Grid Laser for Diffuse Diabetic Maculopathy

Dow University of Health Sciences50 enrolled

Overview

Diabetic related complications are increasing day by day due to increse in the number of diabetic patients all over the world. Diabetic macular edema is one of them and a major cause of vision imparment. Various kind of treatment modalities are preent to treat this coplication. Grid laser is one treatment modality. Laser phtocoagulation is a destrictive procedure.Laser power if kept to aminimum can get the desired results without severe destruction to the retina . In this study, the investigators are going to document the effect of minimal grid laser tn loss o overcome the visioe to diabetic macular edema.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Diabetic Macular Edema

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diabetic patients with macular edema. * both sexes * conset to participate. Exclusion Criteria: * focal edema. * patients requiring only the focal laser. * patients with proferative diabetic retinopathy. * Patients with ischaemic maculopathy on fundus fluorescein angiography.

Locations (1)

Dow universty Hospital,Dow international Medical college

Karachi, Sindh, Pakistan

Outcomes

Primary Outcomes

Improvement of visual acuity after grid laser

Visual acuity will be mesured pre laser and 06 weeks post laser

Time frame: 6 week

Secondary Outcomes

Complication

Patiens willbe asked and examined for any potentiail anticipated complication.

Time frame: during first six weeks after laser

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.